Caleres Non-GAAP EPS of $1.37, revenue of $761.9M
Post Content
Similar Posts
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. Post Views: 73
Dow rallies to year’s highest close, caps blockbuster month
Post Content Post Views: 74
Marketmind: Markets in a holiday mood
Post Content Post Views: 74
Ford to scale back plans for $3.5 billion battery plant as EV demand disappoints, labor costs rise
Ford is scaling back production capacity and expected employment at the battery plant in Michigan. Post Views: 102
Southwest Airlines restructures executive team to boost growth
Post Content Post Views: 76
HubSpot chief technology officer sells over 15K shares
Post Content Post Views: 93